The diabetes vaccine Diamyd® shows positive results
Diamyd Medical today announced results from DIAGNODE-1, when all patients have been followed for 6 months. A clinically relevant and positive progression can be demonstrated in terms of the body’s own capacity to produce insulin, as well as long-term blood sugar and insulin dose. No serious adverse events have been reported."The results seen in DIAGNODE-1 are gratifying, now that all twelve patients have been followed for 6 months," says Johnny Ludvigsson, Professor at Linköping University and Sponsor of the trial. “It is therefore with enthusiasm that we start DIAGNODE-2, where we have now